关注
Parth Anil Desai
Parth Anil Desai
Assistant Professor
在 fccc.edu 的电子邮件经过验证
标题
引用次数
年份
“Cross-over Effect” in survival curves with immune-checkpoint inhibition: Identifying ideal candidates for immunotherapy-only approaches in specific tumor histologies
S Goyal, A Thomas, PA Desai
Cancer Research 84 (6_Supplement), 7537-7537, 2024
2024
A Rare Case of Pearson's Syndrome with Predominant Hematological Manifestations and Novel Mitochondrial Deletion
P Desai, A Saksena, PS Dange, R Gupta, S Kapoor, T Singh
Blood 130 (Supplement 1), 4958-4958, 2017
22017
Abstract CT257: Hyperprogressive disease following bintrafusp alfa and DNA damaging chemotherapy in relapsed small cell lung cancer
B Schroeder, N Takahashi, H Yang, R Donahue, Z Skidmore, A Konicki, ...
Cancer Research 84 (7_Supplement), CT257-CT257, 2024
2024
Abstract CT268: Targeting replication stress and chemotherapy resistance with a combination of sacituzumab govitecan and berzosertib: A phase I clinical trial
ML Abel, N Takahashi, P Desai, C Peer, C Redon, S Nichols, R Vilimas, ...
Cancer Research 83 (8_Supplement), CT268-CT268, 2023
2023
Abstract LB_A10: Efficacy of ATR inhibitor berzosertib plus topotecan or topotecan alone in patients with relapsed small cell lung cancer: A randomized clinical trial
N Takahashi, Z Hao, LC Villaruz, J Zhang, J Ruiz, WJ Petty, H Mamdani, ...
NaN, LB_A10-LB_A10, 2023
2023
Allogeneic stem cell transplantation for HIV-positive patients with hematologic malignancies
VE Mulanovich, PA Desai, UR Popat
Aids 30 (17), 2653-2657, 2016
172016
An affordable, indigenous polarizer-analyser system with inbuilt retardation plate function to detect birefringence using 3d glasses: An experience
DP Anil, DP Sudhir, A Saksena, N Khurana
Journal of Clinical and Diagnostic Research: JCDR 10 (1), EC12, 2016
12016
ATR inhibition augments the efficacy of lurbinectedin in small cell lung cancer
CW Schultz, Y Zhang, R Elmeskini, A Zimmermann, H Fu, Y Murai, ...
bioRxiv, 2022.12. 16.520783, 2022
12022
ATR inhibition augments the efficacy of lurbinectedin in small‐cell lung cancer
CW Schultz, Y Zhang, R Elmeskini, A Zimmermann, H Fu, Y Murai, ...
EMBO Molecular Medicine 15 (8), e17313, 2023
112023
Author Correction: ATR inhibition augments the efficacy of lurbinectedin in small-cell lung cancer
CW Schultz, Y Zhang, R Elmeskini, A Zimmermann, H Fu, Y Murai, ...
EMBO Molecular Medicine 16 (3), 664-664, 2024
2024
Automated detection and segmentation of small cell lung cancer liver metastases on CT.
U Chaudhary, PA Desai, N Takahashi, N Lay, PL Choyke, A Thomas, ...
Journal of Clinical Oncology 40 (16_suppl), e13555-e13555, 2022
2022
Berzosertib plus topotecan vs topotecan alone in patients with relapsed small cell lung cancer: a randomized clinical trial
N Takahashi, Z Hao, LC Villaruz, J Zhang, J Ruiz, WJ Petty, H Mamdani, ...
JAMA oncology 9 (12), 1669-1677, 2023
82023
Bilirubin crystallization in neutrophils in cases of neonatal unconjugated hyperbilirubinemias
P Dange, P Desai, R Gupta, T Singh
Journal of Applied Hematology 5 (3), 117-118, 2014
12014
Breast Cancer in Women Over 65 years- a Review of Screening and Treatment Options
AA Desai P
Clin Geriatr Med, 0
21*
Carcinoma breast masquerading as extramedullary plasmacytoma breast: An unusual case report with review of literature
N Mahajan, A Saksena, P Desai, S Kaushal, S Jain, R Patel
Cancer Treatment Communications 8, 5-7, 2016
2016
CD30 Expression and Its Prognostic Significance in De Novo Diffuse Large B Cell Lymphoma Treated with Rituximab-EPOCH
J Xu, A Saksena, P Desai, P Lin, CC Yin, G Tang, MJ You, LJ Medeiros, ...
LABORATORY INVESTIGATION 96, 386A-386A, 2016
2016
CD30 expression and prognostic significance in R-EPOCH–treated patients with diffuse large B-cell lymphoma
J Xu, Y Oki, A Saksena, P Desai, P Lin, G Tang, CC Yin, MJ You, ...
Human pathology 60, 160-166, 2017
122017
Computational analysis reveals similarities and differences between SCLC subtypes
A Singh, P Desai, M Pillai, N Agarwal, N Takahashi, A Thomas, MK Jolly
bioRxiv, 2021.10. 27.465593, 2021
2021
Cyclic‐AMP signalling, MYC and hypoxia‐inducible factor 1 α intersect to regulate angiogenesis in B‐cell lymphoma
P Ethiraj, B Sasi, KN Holder, AP Lin, Z Qiu, C Jaafar, A Elkhalili, P Desai, ...
British Journal of Haematology 198 (2), 349-359, 2022
32022
Dissecting small cell lung cancer subtypes with cell-free DNA fragmentomes.
L Rinaldi, ZL Skidmore, B Alipanahi, G Graham, B Chesnick, N Takahashi, ...
Journal of Clinical Oncology 41 (16_suppl), 8592-8592, 2023
2023
系统目前无法执行此操作,请稍后再试。
文章 1–20